Unlock Your Next Opportunity at ON Helix!

Unlock Your Next Opportunity at ON Helix!  
ON Helix on 3 July, offers a unique chance to be in Cambridge, connect with industry leaders, and explore the cutting-edge innovations driving the translation of bio innovation into improved patient outcomes.

Join the Conversation
Attend ON Helix to hear from leading voices and learn about:

Harnessing the Body’s Defences
Pioneering research that leverages the body’s own biology for more effective treatments with Louise Jopling, Babraham Research Campus; Lennart Spindler, SV Health Investors; Jake Galson, Alchemab and James Price, East Anglian Air Ambulance.

Adoption of AI in Innovative Drug Discovery
The transformative convergence of biology and technology in next-generation drug discovery with Kinga Bercsenyi, Arctoris; Peter Brady, Orbital Global Group; Rose Hughes, Evolve IP; Anusha Foy, EY; Miles Congreve, Isomorphic Labs, and Catherine Stace, Kuano Limited.

Plus, there’s so much more; check out the full programme.

Partnering Opportunities
Don’t miss out on invaluable meetings with potential collaborators, industry leaders and investors via the conference app, launching next week. Registering will give you faster access to these 1-2-1 partnering opportunities, enabling you to secure dedicated meetings with your key targets.

Who Attends ON Helix?
ON Helix attracts a diverse range of attendees from across the biotech, pharma and tech sectors, along with investors, academic institutions and professional services. A list of companies registered in 2024 can be found here.

For any other queries, including sponsorship, please contact onhelix@onenucleus.com. 

We look forward to seeing you there!